Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography. Guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group
Creators
- 1. Division of Abdominal Imaging, Department of Radiology, Mayo Clinic, 200, First Street SW, 55905, Rochester, MN (United States)
- 2. Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL (United States)
- 3. Joint Department of Medical Imaging, University Health Network, University of Toronto, Toronto, ON (Canada)
- 4. Department of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover (Germany)
- 5. Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN (United States)
- 6. Radiology, Oxford University Hospitals NHS Foundation Trust, Oxford (United Kingdom)
- 7. Department of Radiology, Saint-Antoine Hospital, APHP Sorbonne University, Paris (France)
- 8. Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna (Austria)
- 9. Department of Abdominal Radiology, Karolinska University Hospital, Stockholm (Sweden)
- 10. 1st Department of Medicine, Martin Zeitz Center for Rare Diseases, and Center for Translational Immunology (HCTI), University Medical Center Hamburg-Eppendorf, Hamburg (Germany)
- 11. Department of Radiology, Virginia Commonwealth University, Richmond, VA (United States)
Description
Primary sclerosing cholangitis (PSC) is a chronic inflammatory disorder affecting the bile ducts and is characterized by biliary strictures, progressive liver parenchymal fibrosis, and an increased risk of hepatobiliary malignancies primarily cholangiocarcinoma (CCA). PSC may lead to portal hypertension, liver decompensation, and liver failure with the need for liver transplantation. Magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) are considered the imaging standard for diagnosis and follow-up in patients with PSC. Currently, there are no universally accepted reporting standards and definitions for MRI/MRCP features. Controversies exist about the definition of a high-grade stricture and there is no widely agreed approach to their management. The members of the MRI working group of the International Primary Sclerosing Cholangitis Study Group (IPSCSG) sought to define terminologies and reporting standards for describing MRI/MRCP features that would be applied to diagnosis and surveillance of disease progression, and potentially for evaluating treatment response in clinical trials. In this extensive review, the technique of MRI/MRCP and assessment of image quality for the evaluation of PSC is briefly described. The definitions and terminologies for severity and length of strictures, duct wall thickening and hyperenhancement, and liver parenchyma signal intensity changes are outlined. As CCA is an important complication of PSC, standardized reporting criteria for CCA developing in PSC are summarized. Finally, the guidelines for reporting important changes in follow-up MRI/MRCP studies are provided. Primary sclerosing cholangitis is a chronic inflammatory disorder affecting the bile ducts, causing biliary strictures and liver fibrosis and an increased risk of cholangiocarcinoma. This consensus document provides definitions and suggested reporting standards for MRI and MRCP features of primary sclerosing cholangitis, which will allow for a standardized approach to diagnosis, assessment of disease severity, follow-up, and detection of complications. Standardized definitions and reporting of MRI/MRCP features of PSC will facilitate comparison between studies, promote longitudinal assessment during management, reduce inter-reader variability, and enhance the quality of care and communication between health care providers.
Availability note (English)
Available from: http://dx.doi.org/10.1007/s00330-021-08147-7Additional details
Identifiers
Publishing Information
- Journal Title
- European Radiology (Internet)
- Journal Volume
- 32
- Journal Issue
- 2
- Journal Page Range
- p. 923-937
- ISSN
- 1432-1084
- CODEN
- EURAE3
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 53030441
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BILIARY TRACT; CARCINOMAS; CLINICAL TRIALS; COMPARATIVE EVALUATIONS; DIAGNOSIS; FIBROSIS; HYPERTENSION; INFLAMMATION; LIVER; MEDICAL SURVEILLANCE; NMR IMAGING; PANCREAS; RECOMMENDATIONS; STANDARDIZATION; TRANSPLANTS
- Descriptors DEC
- BODY; CARDIOVASCULAR DISEASES; DIAGNOSTIC TECHNIQUES; DIGESTIVE SYSTEM; DISEASES; ENDOCRINE GLANDS; EVALUATION; GLANDS; NEOPLASMS; ORGANS; PATHOLOGICAL CHANGES; SYMPTOMS; TESTING; VASCULAR DISEASES
Optional Information
- Collaborations
- IPSCSG